Related Experiment Video

Updated: May 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Virus-derived anti-inflammatory proteins: potential therapeutics for cancer

Donghang Zheng1, Hao Chen, Mee Y Bartee

  • 1Department of Medicine, Divisions of Cardiology and Rheumatology, University of Florida, Gainesville, FL 32610-0277, USA.

Trends in Molecular Medicine
|May 5, 2012
PubMed

Insights

Viral anti-inflammatory proteins show promise as novel cancer therapeutics. These proteins target key immune pathways, including proteases and chemokines, crucial for cancer growth and spread.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Inflammation plays a critical role in cancer progression, including cell growth, invasion, and metastasis.
  • Viral proteins possess anti-inflammatory properties that can modulate immune responses.
  • Specific viral-derived inhibitors target key inflammatory mediators like proteases, chemokines, and cytokines.

Purpose of the Study:

  • To review the mechanisms of action of viral immunomodulatory proteins.
  • To explore the potential of these viral proteins as anticancer therapeutics.

Main Methods:

  • Literature review focusing on viral immunomodulatory proteins and their role in inflammation and cancer.
  • Analysis of viral protease, chemokine, cytokine, and apoptosis inhibitors.
  • Examination of the impact on tumor microenvironment, immune cell infiltration, and angiogenesis.

Main Results:

  • Viral proteins effectively target key inflammatory cascades involved in cancer.
  • Virus-derived inhibitors demonstrate potency against cancer-related inflammatory pathways.
  • These proteins modulate critical aspects of the tumor microenvironment.

Conclusions:

  • Viral immunomodulatory proteins represent a promising avenue for novel anticancer therapies.
  • Understanding their mechanisms can lead to targeted therapeutic strategies.
  • Further research into viral anti-inflammatory proteins could yield potent cancer treatments.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...